Bloomberg reports that CNBG (China National Biotec Group Co.) is in talks with the Chinese government regarding vaccinating students before they go abroad to study. No final decision has been made. CNBGs coronavirus vaccines are yet to receive regulatory approval.
The CNBG vaccine, which requires two doses, is undergoing Phase 3 testing. It has been authorized for emergency use in China and has been administered to hundreds of thousands of people there, including medical workers and employees of state-owned companies working in high-risk countries.